CTTH · Ctt Pharmaceutical Holdings, Inc.
Market Cap
$1.07M
Shares
21.35M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.05
Open$0.06
Day$0.05–0.06
52W close$0.04–0.10
Avg vol 30d51K
Short int5K · 0.0% float · 1.0d
Short vol99%
DataJan 2020–Sep 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
−$1.67M
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
1.6
Trailing earnings · reciprocal yield 61.3%
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+35.2%
Year over year · more shares
Price change (1Y)
-10.1%
Trailing year
Short interest
0.0%
Latest settlement · 1.0 days to cover
Equibles Rating
blended score · not investment adviceOverall
Strong Sell
SellHoldBuy
Technical
Strong Sell
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 14.3 · calm
Equity put/call 0.47
Technical
price trend
50 / 200-day cross
Death cross
Price vs 200-day avg
−26%
below
Price vs 50-day avg
−23%
below
RSI (14)
35
neutral
MACD trend
Negative
52-week position
21%
mid-range
Momentum
relative strength
1-month return
−23%
trailing
6-month return
−38%
trailing
YTD return
−17%
this year
Relative strength
−54%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
Death cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow
Flat
No 13F holder data
Insider flow
Accumulating
Net +$2.2K over 90 days · 0% sells
Short interest
Falling
0.02% of float · ▼ -74.0% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Squeeze score
17
low risk · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
172%
annualized · 1-yr
Max drawdown
−52%
past year
ATR
12.0%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Strong Sell
50 / 200-day cross
Death cross
Bearish
Price vs 200-day avg
−26%
Bearish
Price vs 50-day avg
−23%
Bearish
RSI (14)
35
Neutral
MACD trend
Negative
Bearish
52-week position
21%
Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
Death cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow
Flat
No 13F holder data
Insider flow
Accumulating
Net +$2.2K over 90 days · 0% sells
Short interest
Falling
0.02% of float · ▼ -74.0% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Price context
position in its 52-week range
Range low $0
Now $0 · 21%
Range high $0
vs 200-day avg -26%
vs 50-day avg -23%
50-day below 200-day death cross
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Drug Manufacturers - Specialty & Generic — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
CTTH
this stock
Ctt Pharmaceutical Holdings, Inc.
|
$1.07M | -16.8% | — | — | 0.0% |
|
JHPCY
Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR
|
$66.37B | — | — | — | 0.0% |
|
TAK
Takeda Pharmaceutical Co Ltd
|
$58.66B | +20.0% | — | — | 0.1% |
|
GALDY
Galderma Group AG/ADR
|
$47.50B | -2.8% | — | — | 0.0% |
|
TEVA
Teva Pharmaceutical Industries Ltd
|
$43.03B | +17.3% | +4.3% | 60.5 | 3.1% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionShort & Settlement
Smart Money
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| CTTH | +0.0% | -23.1% | -37.5% | +2.5% | -16.8% |
| SPY | +0.3% | +0.6% | +16.7% | +0.8% | +13.4% |
| vs SPY | -0.3% | -23.7% | -54.2% | +1.7% | -30.2% |